Molecular dissection of mutations at the heterozygous thymidine kinase locus in mouse lymphoma cells.
Marcia Applegate,Martha M. Moore,C B Broder,A Burrell,G Juhn,K L Kasweck,P F Lin,A Wadhams,John C. Hozier +8 more
TL;DR: The variety of mutagenic lesions recorded at the heterozygous Tk locus may be representative of events observed in human malignancy and may include a wider range ofmutagenic events than can be observed at hemizygous test loci.
read more
Abstract: The mouse lymphoma L5178Y TK+/- 3.7.2C cell line allows quantitation of induced TK(+/-)----TK-/- mutations at the heterozygous thymidine kinase (Tk) locus. TK-/- mutant colonies show a bimodal size distribution, reflecting a difference in the growth rates of the two size classes that is hypothesized to result from different degrees of genetic damage. The two homologous chromosomes 11 containing the alleles of the Tk gene in L5178Y 3.7.2C TK+/- cells are distinguishable at the cytogenetic level. We find, in addition, that the two alleles are distinguishable at the molecular level because of an Nco I restriction fragment length polymorphism at the 3' end of the gene. In a set of 51 large-colony and 48 small-colony TK-/- mutants induced by ionizing radiation or by chemical mutagens, we find that 78, including all except one of the small-colony mutants, have lost the Tk+ allele and that some of these have two to four copies of the remaining Tk- allele. Nineteen of the large-colony TK-/- mutants that do not show Tk+ allele loss show no other structural changes detectable at the level of Southern blot analysis. One shows a partial deletion. The variety of mutagenic lesions recorded at the heterozygous Tk locus may be representative of events observed in human malignancy and may include a wider range of mutagenic events than can be observed at hemizygous test loci.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
ICH-harmonised guidances on genotoxicity testing of pharmaceuticals: evolution, reasoning and impact.
Lutz Müller,Yasumoto Kikuchi,Gregory S. Probst,Leonard Schechtman,Hiroyasu Shimada,Toshio Sofuni,David Tweats +6 more
TL;DR: The authors are fully aware of the fact that some of the recommendations given in these ICH guidances are transient in nature and that the dynamic qualities and ongoing evolution of genetic toxicology makes necessary a continuous maintenance process that would serve to update the guidance as necessary.
164
Considerations in the U.S. Environmental Protection Agency's testing approach for mutagenicity
TL;DR: It is felt that the revised Subdivision F guideline will provide appropriate, and more specific, guidance concerning the OPP approach to mutagenicity testing for the registration of a pesticide in accordance with the Agency's Carcinogen Risk Assessment Guidelines.
127
The Mouse Lymphoma Assay
TL;DR: The emphasis will be on a typical microwell protocol but an attempt will be made to highlight protocol variations between laboratories and between the microwell and agar versions of the assay.
103
Ionizing radiation and genetic risks III. Nature of spontaneous and radiation-induced mutations in mammalian in vitro systems and mechanisms of induction of mutations by radiation
TL;DR: Whether the molecular nature and mechanisms of origin of radiation-induced mutations, in mammalian in vivo and in vitro systems, as currently understood, are consistent with expectations based on the biophysical and microdosimetric properties of ionizing radiation is examined.
103
Genotoxicity Assessment of Nanomaterials: Recommendations on Best Practices, Assays, and Methods.
Rosalie K. Elespuru,Stefan Pfuhler,Marilyn J. Aardema,Tao Chen,Shareen H. Doak,Ann T. Doherty,Christopher S Farabaugh,Julia Kenny,Mugimane G. Manjanatha,Brinda Mahadevan,Martha M. Moore,Gladys Ouedraogo,Leon F. Stankowski,Jennifer Y. Tanir +13 more
TL;DR: A revised genotoxicity test battery for NMs is proposed that includes in vitro mammalian cell mutagenicity and clastogenicity assessments; in vivo assessments would be added only if warranted by information on specific organ exposure or sequestration of NMs.
95
References
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.
TL;DR: In this article, the rat pancreas RNA was used as a source for the purification of alpha-amylase messenger ribonucleic acid (RBA) using 2-mercaptoethanol.
22.3K
•Book
Handbook of mutagenicity test procedures
B. J. Kilbey
- 01 Jan 1977
TL;DR: This book consists of 39 chapters and some of the titles are: Bacillus subtilis repair test, Induced reversion using human adenovirus, The fluctuation test in bacteria, Chemical mutagenesis with diploid human fibroblasts, The specific locus test in the mouse, The bone marrow micronucleus test, and Sperm morphology in testing in mice.
567
Validation and characterization of the L5178Y/TK+/- mouse lymphoma mutagen assay system.
TL;DR: Characterization of the TK-/- mutants suggests that two mutagenic mechanisms contribute to their final yield, and is consistent with the induction of slow-growing specific locus mutants by a chromosomal mechanism and their subsequent dilution during this long expression time.
538
Chromosomal Deletion and Retinoblastoma
TL;DR: A new case of a deletion of the long arm of chromosome 13 is reported and its relation to previously reported cases is considered and the relation between the two genetic groups is considered.
286
Direct identification of sickle cell anemia by blot hybridization
Robert F. Geever,Lois B. Wilson,Ferez S. Nallaseth,Paul F. Milner,Michael L. Bittner,John Wilson +5 more
TL;DR: By use of restriction endonuclease Dde I and diazobenzyloxymethyl-paper transfer procedures, a direct analysis can be made of polymorphisms found in the human hemoglobin genes and the application to prenatal diagnosis of sickle cell anemia should be possible.
168